[
    {
        "id": 3906,
        "drug_name": "ALKS 5461",
        "clinical_trial_id": "",
        "has_trial_insight_page": 0,
        "indication": "Major depressive disorder",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2019-02-01",
        "link": "http:\/\/investor.alkermes.com\/phoenix.zhtml?c=92211&p=irol-newsArticle&ID=2385782",
        "note": "CRL announced February 1, 2019.  ",
        "company_entity_id": 31,
        "company_ticker": "ALKS",
        "company_name": "Alkermes plc",
        "company_price": "29.5700",
        "company_change": 0.66,
        "company_percent_change": 2.2800000000000002,
        "company_optionable": 1,
        "company_number_of_shares": 167076133,
        "price_change_sparkline": [
            [
                28.62,
                1704171600
            ],
            [
                28.67,
                1704258000
            ],
            [
                28.63,
                1704344400
            ],
            [
                28.56,
                1704430800
            ],
            [
                29.6,
                1704690000
            ],
            [
                28.98,
                1704776400
            ],
            [
                28.15,
                1704862800
            ],
            [
                27.94,
                1704949200
            ],
            [
                28.2,
                1705035600
            ],
            [
                27.76,
                1705381200
            ],
            [
                27.69,
                1705467600
            ],
            [
                27.76,
                1705554000
            ],
            [
                27.9,
                1705640400
            ],
            [
                28.46,
                1705899600
            ],
            [
                28.54,
                1705986000
            ],
            [
                28.12,
                1706072400
            ],
            [
                28.02,
                1706158800
            ],
            [
                27.74,
                1706245200
            ],
            [
                28.31,
                1706504400
            ],
            [
                27.41,
                1706590800
            ],
            [
                27.05,
                1706677200
            ],
            [
                26.94,
                1706763600
            ],
            [
                26.74,
                1706850000
            ],
            [
                26.4,
                1707109200
            ],
            [
                27.04,
                1707195600
            ],
            [
                26.7,
                1707282000
            ],
            [
                26.77,
                1707368400
            ],
            [
                27.32,
                1707454800
            ],
            [
                28.52,
                1707714000
            ],
            [
                27.23,
                1707800400
            ],
            [
                27.99,
                1707886800
            ],
            [
                32.56,
                1707973200
            ],
            [
                32.18,
                1708059600
            ],
            [
                30.39,
                1708405200
            ],
            [
                29.18,
                1708491600
            ],
            [
                28.91,
                1708578000
            ],
            [
                29.57,
                1708664400
            ]
        ],
        "statuses": []
    },
    {
        "id": 2357,
        "drug_name": "EDSIVO (celiprolol) - (DiSCOVER)",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Vascular Ehlers-Danlos Syndrome",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2019-06-25",
        "link": "https:\/\/www.globenewswire.com\/news-release\/2019\/06\/25\/1873784\/0\/en\/Acer-Therapeutics-Receives-Complete-Response-Letter-from-U-S-FDA-for-use-of-EDSIVO-celiprolol-in-vEDS-Patients.html",
        "note": "CRL issued June 25, 2019.",
        "company_entity_id": 2030,
        "company_ticker": "ZVRA",
        "company_name": "Zevra Therapeutics Inc.",
        "company_price": "6.6300",
        "company_change": -0.17000000000000004,
        "company_percent_change": -2.5,
        "company_optionable": 1,
        "company_number_of_shares": 36218164,
        "price_change_sparkline": [
            [
                6.83,
                1704171600
            ],
            [
                6.42,
                1704258000
            ],
            [
                6.15,
                1704344400
            ],
            [
                5.94,
                1704430800
            ],
            [
                6.35,
                1704690000
            ],
            [
                6.185,
                1704776400
            ],
            [
                6.02,
                1704862800
            ],
            [
                6.03,
                1704949200
            ],
            [
                5.92,
                1705035600
            ],
            [
                5.82,
                1705381200
            ],
            [
                5.76,
                1705467600
            ],
            [
                5.71,
                1705554000
            ],
            [
                5.72,
                1705640400
            ],
            [
                5.97,
                1705899600
            ],
            [
                5.94,
                1705986000
            ],
            [
                5.74,
                1706072400
            ],
            [
                5.87,
                1706158800
            ],
            [
                5.975,
                1706245200
            ],
            [
                6.17,
                1706504400
            ],
            [
                5.93,
                1706590800
            ],
            [
                5.79,
                1706677200
            ],
            [
                5.96,
                1706763600
            ],
            [
                5.78,
                1706850000
            ],
            [
                5.77,
                1707109200
            ],
            [
                5.905,
                1707195600
            ],
            [
                5.81,
                1707282000
            ],
            [
                5.95,
                1707368400
            ],
            [
                6.15,
                1707454800
            ],
            [
                6.11,
                1707714000
            ],
            [
                5.76,
                1707800400
            ],
            [
                6.14,
                1707886800
            ],
            [
                6.68,
                1707973200
            ],
            [
                6.86,
                1708059600
            ],
            [
                6.89,
                1708405200
            ],
            [
                6.78,
                1708491600
            ],
            [
                6.8,
                1708578000
            ],
            [
                6.63,
                1708664400
            ]
        ],
        "statuses": [
            {
                "label": "Breakthrough Therapy Designation (BTD)",
                "abbreviation": "BTD",
                "description": "Breakthrough Therapy Designation (BTD)",
                "description_html": "<p>Breakthrough Therapy Designation (BTD)<\/p>\n"
            }
        ]
    },
    {
        "id": 2549,
        "drug_name": "Riluzole (BHV-0223)",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Amyotrophic lateral sclerosis (ALS)",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2019-07-19",
        "link": "https:\/\/www.biohavenpharma.com\/investors\/news-events\/press-releases\/07-20-2019",
        "note": "CRL issued July 19, 2019.",
        "company_entity_id": 387,
        "company_ticker": "PFE",
        "company_name": "Pfizer Inc.",
        "company_price": "27.7600",
        "company_change": 0.21,
        "company_percent_change": 0.76,
        "company_optionable": 1,
        "company_number_of_shares": 5646413292,
        "price_change_sparkline": [
            [
                29.2822911437791,
                1704171600
            ],
            [
                29.2822911437791,
                1704258000
            ],
            [
                28.6519290068125,
                1704344400
            ],
            [
                29.0262065256364,
                1704430800
            ],
            [
                29.1345500179276,
                1704690000
            ],
            [
                28.9572606669057,
                1704776400
            ],
            [
                28.5534349229114,
                1704862800
            ],
            [
                27.9723198278953,
                1704949200
            ],
            [
                28.2678020795984,
                1705035600
            ],
            [
                27.8935245607745,
                1705381200
            ],
            [
                27.7260846181427,
                1705467600
            ],
            [
                27.6669881678021,
                1705554000
            ],
            [
                27.8541269272141,
                1705640400
            ],
            [
                27.8836751523844,
                1705899600
            ],
            [
                28.0018680530656,
                1705986000
            ],
            [
                27.9033739691646,
                1706072400
            ],
            [
                27.47,
                1706158800
            ],
            [
                27.47,
                1706245200
            ],
            [
                27.48,
                1706504400
            ],
            [
                27.02,
                1706590800
            ],
            [
                27.08,
                1706677200
            ],
            [
                27.29,
                1706763600
            ],
            [
                26.93,
                1706850000
            ],
            [
                26.57,
                1707109200
            ],
            [
                27.5,
                1707195600
            ],
            [
                27.56,
                1707282000
            ],
            [
                27.57,
                1707368400
            ],
            [
                27.56,
                1707454800
            ],
            [
                27.66,
                1707714000
            ],
            [
                26.97,
                1707800400
            ],
            [
                27.11,
                1707886800
            ],
            [
                27.51,
                1707973200
            ],
            [
                27.62,
                1708059600
            ],
            [
                27.59,
                1708405200
            ],
            [
                27.67,
                1708491600
            ],
            [
                27.55,
                1708578000
            ],
            [
                27.76,
                1708664400
            ]
        ],
        "statuses": []
    },
    {
        "id": 2549,
        "drug_name": "Riluzole (BHV-0223)",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Amyotrophic lateral sclerosis (ALS)",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2019-07-19",
        "link": "https:\/\/www.biohavenpharma.com\/investors\/news-events\/press-releases\/07-20-2019",
        "note": "CRL issued July 19, 2019.",
        "company_entity_id": 409,
        "company_ticker": "BHVN",
        "company_name": "Biohaven Ltd.",
        "company_price": "47.3100",
        "company_change": -0.020000000000000018,
        "company_percent_change": -0.040000000000000036,
        "company_optionable": 1,
        "company_number_of_shares": 80233656,
        "price_change_sparkline": [
            [
                41.93,
                1704171600
            ],
            [
                40.19,
                1704258000
            ],
            [
                42.36,
                1704344400
            ],
            [
                42.59,
                1704430800
            ],
            [
                47.06,
                1704690000
            ],
            [
                47.71,
                1704776400
            ],
            [
                46.5,
                1704862800
            ],
            [
                45.46,
                1704949200
            ],
            [
                45.34,
                1705035600
            ],
            [
                44.6,
                1705381200
            ],
            [
                43.49,
                1705467600
            ],
            [
                42.71,
                1705554000
            ],
            [
                44.35,
                1705640400
            ],
            [
                48.45,
                1705899600
            ],
            [
                48.31,
                1705986000
            ],
            [
                45.6,
                1706072400
            ],
            [
                44.97,
                1706158800
            ],
            [
                44.89,
                1706245200
            ],
            [
                45.67,
                1706504400
            ],
            [
                43.81,
                1706590800
            ],
            [
                44.48,
                1706677200
            ],
            [
                45,
                1706763600
            ],
            [
                44.79,
                1706850000
            ],
            [
                47.16,
                1707109200
            ],
            [
                47.21,
                1707195600
            ],
            [
                47.26,
                1707282000
            ],
            [
                46.92,
                1707368400
            ],
            [
                48.55,
                1707454800
            ],
            [
                48.71,
                1707714000
            ],
            [
                46.95,
                1707800400
            ],
            [
                47.12,
                1707886800
            ],
            [
                49.11,
                1707973200
            ],
            [
                49.5,
                1708059600
            ],
            [
                47.24,
                1708405200
            ],
            [
                46.57,
                1708491600
            ],
            [
                47.33,
                1708578000
            ],
            [
                47.31,
                1708664400
            ]
        ],
        "statuses": []
    },
    {
        "id": 3974,
        "drug_name": "HETLIOZ (tasimelteon)",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Jet Lag Disorder",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2019-08-19",
        "link": "https:\/\/vandapharmaceuticalsinc.gcs-web.com\/news-releases\/news-release-details\/vanda-pharmaceuticals-fda-update-hetliozr-treatment-jet-lag-0",
        "note": "CRL issued August 19, 2019.",
        "company_entity_id": 305,
        "company_ticker": "VNDA",
        "company_name": "Vanda Pharmaceuticals Inc.",
        "company_price": "4.4500",
        "company_change": 0.12,
        "company_percent_change": 2.77,
        "company_optionable": 1,
        "company_number_of_shares": 57537499,
        "price_change_sparkline": [
            [
                4.52,
                1704171600
            ],
            [
                4.28,
                1704258000
            ],
            [
                4.23,
                1704344400
            ],
            [
                4.19,
                1704430800
            ],
            [
                4.26,
                1704690000
            ],
            [
                4.17,
                1704776400
            ],
            [
                3.94,
                1704862800
            ],
            [
                3.92,
                1704949200
            ],
            [
                3.85,
                1705035600
            ],
            [
                3.76,
                1705381200
            ],
            [
                3.76,
                1705467600
            ],
            [
                3.69,
                1705554000
            ],
            [
                3.66,
                1705640400
            ],
            [
                3.79,
                1705899600
            ],
            [
                3.71,
                1705986000
            ],
            [
                3.67,
                1706072400
            ],
            [
                3.79,
                1706158800
            ],
            [
                3.75,
                1706245200
            ],
            [
                3.8,
                1706504400
            ],
            [
                3.65,
                1706590800
            ],
            [
                3.6,
                1706677200
            ],
            [
                3.73,
                1706763600
            ],
            [
                3.63,
                1706850000
            ],
            [
                3.47,
                1707109200
            ],
            [
                3.73,
                1707195600
            ],
            [
                3.64,
                1707282000
            ],
            [
                4.07,
                1707368400
            ],
            [
                4.16,
                1707454800
            ],
            [
                4.33,
                1707714000
            ],
            [
                4.06,
                1707800400
            ],
            [
                4.25,
                1707886800
            ],
            [
                4.37,
                1707973200
            ],
            [
                4.38,
                1708059600
            ],
            [
                4.35,
                1708405200
            ],
            [
                4.34,
                1708491600
            ],
            [
                4.33,
                1708578000
            ],
            [
                4.45,
                1708664400
            ]
        ],
        "statuses": []
    },
    {
        "id": 6100,
        "drug_name": "PT010",
        "clinical_trial_id": "",
        "has_trial_insight_page": 0,
        "indication": "Chronic obstructive pulmonary disease (COPD)",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2019-10-01",
        "link": "https:\/\/www.astrazeneca.com\/content\/astraz\/media-centre\/press-releases\/2019\/update-on-us-regulatory-review-of-pt010-in-copd-01102019.html",
        "note": "CRL announced October 1, 2019.",
        "company_entity_id": 374,
        "company_ticker": "AZN",
        "company_name": "AstraZeneca PLC",
        "company_price": "65.8300",
        "company_change": 1.7,
        "company_percent_change": 2.65,
        "company_optionable": 1,
        "company_number_of_shares": 3100378676,
        "price_change_sparkline": [
            [
                67.3653075328265,
                1704171600
            ],
            [
                67.2865176994548,
                1704258000
            ],
            [
                67.7395592413422,
                1704344400
            ],
            [
                67.3456100744836,
                1704430800
            ],
            [
                68.1630545957153,
                1704690000
            ],
            [
                67.8675927205713,
                1704776400
            ],
            [
                68.517608845888,
                1704862800
            ],
            [
                68.1335084082009,
                1704949200
            ],
            [
                68.3698779083161,
                1705035600
            ],
            [
                66.2524011364509,
                1705381200
            ],
            [
                65.2478307609614,
                1705467600
            ],
            [
                65.513746448591,
                1705554000
            ],
            [
                65.5334439069339,
                1705640400
            ],
            [
                66.1243676572218,
                1705899600
            ],
            [
                65.7402672195347,
                1705986000
            ],
            [
                65.5925362819627,
                1706072400
            ],
            [
                66.0061829071642,
                1706158800
            ],
            [
                66.084972740536,
                1706245200
            ],
            [
                66.1736113030792,
                1706504400
            ],
            [
                66.1834600322506,
                1706590800
            ],
            [
                65.6319311986485,
                1706677200
            ],
            [
                65.8387545112493,
                1706763600
            ],
            [
                64.647058281502,
                1706850000
            ],
            [
                64.1546218229287,
                1707109200
            ],
            [
                66.0258803655072,
                1707195600
            ],
            [
                65.5432926361053,
                1707282000
            ],
            [
                62.5591276971512,
                1707368400
            ],
            [
                61.3181878215465,
                1707454800
            ],
            [
                60.4810458419719,
                1707714000
            ],
            [
                60.1067941334562,
                1707800400
            ],
            [
                60.7272640712585,
                1707886800
            ],
            [
                61.8894141134915,
                1707973200
            ],
            [
                63.2977823850111,
                1708059600
            ],
            [
                64.056134531214,
                1708405200
            ],
            [
                64.1053781770713,
                1708491600
            ],
            [
                64.13,
                1708578000
            ],
            [
                65.83,
                1708664400
            ]
        ],
        "statuses": []
    },
    {
        "id": 5359,
        "drug_name": "Cosyntropin depot",
        "clinical_trial_id": "",
        "has_trial_insight_page": 0,
        "indication": "Adrenocortical insufficiency screening",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2019-10-21",
        "link": "http:\/\/investor.assertiotx.com\/news-releases\/news-release-details\/assertio-therapeutics-provides-regulatory-update-long-acting",
        "note": "CRL announced October 21, 2019.",
        "company_entity_id": 622,
        "company_ticker": "ASRT",
        "company_name": "Assertio Holdings Inc.",
        "company_price": "0.8200",
        "company_change": 0.02,
        "company_percent_change": 1.8599999999999999,
        "company_optionable": 1,
        "company_number_of_shares": 94668523,
        "price_change_sparkline": [
            [
                1.14,
                1704171600
            ],
            [
                1.015,
                1704258000
            ],
            [
                0.9043,
                1704344400
            ],
            [
                1.02,
                1704430800
            ],
            [
                0.965,
                1704690000
            ],
            [
                0.9181,
                1704776400
            ],
            [
                0.9292,
                1704862800
            ],
            [
                0.9016,
                1704949200
            ],
            [
                0.9054,
                1705035600
            ],
            [
                0.9175,
                1705381200
            ],
            [
                0.8803,
                1705467600
            ],
            [
                0.8183,
                1705554000
            ],
            [
                0.842,
                1705640400
            ],
            [
                0.8721,
                1705899600
            ],
            [
                0.8456,
                1705986000
            ],
            [
                0.8744,
                1706072400
            ],
            [
                0.8858,
                1706158800
            ],
            [
                0.8777,
                1706245200
            ],
            [
                0.93,
                1706504400
            ],
            [
                0.8941,
                1706590800
            ],
            [
                0.8826,
                1706677200
            ],
            [
                0.8242,
                1706763600
            ],
            [
                0.785,
                1706850000
            ],
            [
                0.7882,
                1707109200
            ],
            [
                0.7975,
                1707195600
            ],
            [
                0.7931,
                1707282000
            ],
            [
                0.793,
                1707368400
            ],
            [
                0.8009,
                1707454800
            ],
            [
                0.8642,
                1707714000
            ],
            [
                0.8014,
                1707800400
            ],
            [
                0.8088,
                1707886800
            ],
            [
                0.8453,
                1707973200
            ],
            [
                0.8545,
                1708059600
            ],
            [
                0.8231,
                1708405200
            ],
            [
                0.7892,
                1708491600
            ],
            [
                0.805,
                1708578000
            ],
            [
                0.82,
                1708664400
            ]
        ],
        "statuses": []
    },
    {
        "id": 4417,
        "drug_name": "JARDIANCE (empagliflozin)",
        "clinical_trial_id": "",
        "has_trial_insight_page": 0,
        "indication": "Type 1 Diabetes",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2020-03-20",
        "link": "https:\/\/investor.lilly.com\/news-releases\/news-release-details\/us-fda-issues-complete-response-letter-empagliflozin-25-mg",
        "note": "CRL announced March 20, 2020.",
        "company_entity_id": 382,
        "company_ticker": "LLY",
        "company_name": "Eli Lilly and Company",
        "company_price": "769.5400",
        "company_change": -0.09999999999999998,
        "company_percent_change": -0.010000000000000009,
        "company_optionable": 1,
        "company_number_of_shares": 950164452,
        "price_change_sparkline": [
            [
                591.185170245581,
                1704171600
            ],
            [
                616.641471902559,
                1704258000
            ],
            [
                613.446955616193,
                1704344400
            ],
            [
                617.490015291125,
                1704430800
            ],
            [
                624.957197110505,
                1704690000
            ],
            [
                624.408139623786,
                1704776400
            ],
            [
                629.110068282781,
                1704862800
            ],
            [
                634.630591740156,
                1704949200
            ],
            [
                641.81825338448,
                1705035600
            ],
            [
                633.482562449744,
                1705381200
            ],
            [
                627.832261768234,
                1705467600
            ],
            [
                622.281789720673,
                1705554000
            ],
            [
                627.502827276203,
                1705640400
            ],
            [
                629.798885857028,
                1705899600
            ],
            [
                628.600942249641,
                1705986000
            ],
            [
                632.614053334388,
                1706072400
            ],
            [
                626.544472390293,
                1706158800
            ],
            [
                638.154542518554,
                1706245200
            ],
            [
                643.894688970617,
                1706504400
            ],
            [
                643.874723243828,
                1706590800
            ],
            [
                644.503643637706,
                1706677200
            ],
            [
                659.298247188938,
                1706763600
            ],
            [
                666.505874560051,
                1706850000
            ],
            [
                704.989812947364,
                1707109200
            ],
            [
                703.821817930162,
                1707195600
            ],
            [
                724.13694493877,
                1707282000
            ],
            [
                734.41929423551,
                1707368400
            ],
            [
                738.891617036422,
                1707454800
            ],
            [
                735.996586651903,
                1707714000
            ],
            [
                741.696801650387,
                1707800400
            ],
            [
                757.31,
                1707886800
            ],
            [
                757.78,
                1707973200
            ],
            [
                782.06,
                1708059600
            ],
            [
                755.66,
                1708405200
            ],
            [
                745.91,
                1708491600
            ],
            [
                769.64,
                1708578000
            ],
            [
                769.54,
                1708664400
            ]
        ],
        "statuses": []
    },
    {
        "id": 5782,
        "drug_name": "RIZAPORT (RHB-103)",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Migraine",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2020-03-27",
        "link": "http:\/\/www.intelgenx.com\/investors\/press-releases\/press-release-details\/2020\/IntelGenx-Receives-Complete-Response-Letter-from-FDA-for-RIZAPORT-NDA\/default.aspx",
        "note": "CRL announced March 27, 2020.",
        "company_entity_id": 623,
        "company_ticker": "IGXT",
        "company_name": "IntelGenx Technologies Corp",
        "company_price": "0.1465",
        "company_change": 0,
        "company_percent_change": -0.7,
        "company_optionable": 0,
        "company_number_of_shares": 174658096,
        "price_change_sparkline": [
            [
                0.143,
                1704171600
            ],
            [
                0.1449,
                1704258000
            ],
            [
                0.13905,
                1704344400
            ],
            [
                0.14,
                1704430800
            ],
            [
                0.13555,
                1704690000
            ],
            [
                0.1621,
                1704776400
            ],
            [
                0.14834,
                1704862800
            ],
            [
                0.161,
                1704949200
            ],
            [
                0.175,
                1705035600
            ],
            [
                0.1659,
                1705381200
            ],
            [
                0.17,
                1705467600
            ],
            [
                0.15,
                1705554000
            ],
            [
                0.16,
                1705640400
            ],
            [
                0.16545,
                1705899600
            ],
            [
                0.153185,
                1705986000
            ],
            [
                0.14,
                1706072400
            ],
            [
                0.14125,
                1706158800
            ],
            [
                0.1385,
                1706245200
            ],
            [
                0.1492,
                1706504400
            ],
            [
                0.15102,
                1706590800
            ],
            [
                0.150855,
                1706677200
            ],
            [
                0.156,
                1706763600
            ],
            [
                0.1468,
                1706850000
            ],
            [
                0.1534,
                1707109200
            ],
            [
                0.16,
                1707195600
            ],
            [
                0.1505,
                1707282000
            ],
            [
                0.15,
                1707368400
            ],
            [
                0.143,
                1707454800
            ],
            [
                0.15,
                1707714000
            ],
            [
                0.1401,
                1707800400
            ],
            [
                0.1485,
                1707886800
            ],
            [
                0.145,
                1707973200
            ],
            [
                0.15,
                1708059600
            ],
            [
                0.155,
                1708405200
            ],
            [
                0.1458,
                1708491600
            ],
            [
                0.147575,
                1708578000
            ],
            [
                0.146545,
                1708664400
            ]
        ],
        "statuses": []
    },
    {
        "id": 2486,
        "drug_name": "Trevyent",
        "clinical_trial_id": "",
        "has_trial_insight_page": 0,
        "indication": "Pulmonary Arterial Hypertension (PAH)",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2020-04-28",
        "link": "https:\/\/www.prnewswire.com\/news-releases\/united-therapeutics-corporation-reports-first-quarter-2020-financial-results-301048809.html",
        "note": "CRL announced April 29, 2020.",
        "company_entity_id": 300,
        "company_ticker": "UTHR",
        "company_name": "United Therapeutics Corporation",
        "company_price": "227.0300",
        "company_change": 9.43,
        "company_percent_change": 4.33,
        "company_optionable": 1,
        "company_number_of_shares": 47058545,
        "price_change_sparkline": [
            [
                227.35,
                1704171600
            ],
            [
                228.18,
                1704258000
            ],
            [
                230.11,
                1704344400
            ],
            [
                229.4,
                1704430800
            ],
            [
                231.04,
                1704690000
            ],
            [
                224.36,
                1704776400
            ],
            [
                221.66,
                1704862800
            ],
            [
                220.3,
                1704949200
            ],
            [
                219.05,
                1705035600
            ],
            [
                218.72,
                1705381200
            ],
            [
                222.25,
                1705467600
            ],
            [
                219.11,
                1705554000
            ],
            [
                217.84,
                1705640400
            ],
            [
                216.24,
                1705899600
            ],
            [
                217.79,
                1705986000
            ],
            [
                218.81,
                1706072400
            ],
            [
                219.32,
                1706158800
            ],
            [
                218.01,
                1706245200
            ],
            [
                216.91,
                1706504400
            ],
            [
                215.02,
                1706590800
            ],
            [
                214.78,
                1706677200
            ],
            [
                215.97,
                1706763600
            ],
            [
                213.41,
                1706850000
            ],
            [
                212.76,
                1707109200
            ],
            [
                214.95,
                1707195600
            ],
            [
                210.76,
                1707282000
            ],
            [
                211.74,
                1707368400
            ],
            [
                212.34,
                1707454800
            ],
            [
                216.25,
                1707714000
            ],
            [
                213.75,
                1707800400
            ],
            [
                214.43,
                1707886800
            ],
            [
                214.54,
                1707973200
            ],
            [
                214.73,
                1708059600
            ],
            [
                214.16,
                1708405200
            ],
            [
                219.18,
                1708491600
            ],
            [
                217.6,
                1708578000
            ],
            [
                227.03,
                1708664400
            ]
        ],
        "statuses": []
    },
    {
        "id": 6300,
        "drug_name": "AYVAKIT (avapritinib)",
        "clinical_trial_id": "",
        "has_trial_insight_page": 0,
        "indication": "Fourth-line GIST ",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2020-05-15",
        "link": "http:\/\/ir.blueprintmedicines.com\/news-releases\/news-release-details\/blueprint-medicines-receives-complete-response-letter-fda",
        "note": "CRL issued May 15, 2020.",
        "company_entity_id": 439,
        "company_ticker": "BPMC",
        "company_name": "Blueprint Medicines Corporation",
        "company_price": "89.4900",
        "company_change": 3.49,
        "company_percent_change": 4.06,
        "company_optionable": 1,
        "company_number_of_shares": 61232297,
        "price_change_sparkline": [
            [
                91.07,
                1704171600
            ],
            [
                88.74,
                1704258000
            ],
            [
                85.21,
                1704344400
            ],
            [
                82.97,
                1704430800
            ],
            [
                85.31,
                1704690000
            ],
            [
                82.98,
                1704776400
            ],
            [
                83.19,
                1704862800
            ],
            [
                81.95,
                1704949200
            ],
            [
                82.93,
                1705035600
            ],
            [
                80.52,
                1705381200
            ],
            [
                79.38,
                1705467600
            ],
            [
                79.68,
                1705554000
            ],
            [
                81.05,
                1705640400
            ],
            [
                83.02,
                1705899600
            ],
            [
                83.1,
                1705986000
            ],
            [
                81.88,
                1706072400
            ],
            [
                81.69,
                1706158800
            ],
            [
                81.56,
                1706245200
            ],
            [
                85.05,
                1706504400
            ],
            [
                83.52,
                1706590800
            ],
            [
                79.53,
                1706677200
            ],
            [
                79.88,
                1706763600
            ],
            [
                79.58,
                1706850000
            ],
            [
                76.66,
                1707109200
            ],
            [
                77.17,
                1707195600
            ],
            [
                74.2,
                1707282000
            ],
            [
                74.16,
                1707368400
            ],
            [
                76.54,
                1707454800
            ],
            [
                77.54,
                1707714000
            ],
            [
                73.17,
                1707800400
            ],
            [
                76.8,
                1707886800
            ],
            [
                87.57,
                1707973200
            ],
            [
                90.26,
                1708059600
            ],
            [
                91.25,
                1708405200
            ],
            [
                87.26,
                1708491600
            ],
            [
                86,
                1708578000
            ],
            [
                89.49,
                1708664400
            ]
        ],
        "statuses": []
    },
    {
        "id": 5028,
        "drug_name": "Contepo",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Complicated urinary tract infections (cUTI)",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2020-06-19",
        "link": "https:\/\/www.benzinga.com\/pressreleases\/20\/06\/g16322739\/nabriva-therapeutics-receives-complete-response-letter-from-fda-on-nda-for-contepo-fosfomycin-for-",
        "note": "CRL issued April 30, 2019. Further CRL received June 19, 2020.",
        "company_entity_id": 206,
        "company_ticker": "NBRV",
        "company_name": "Nabriva Therapeutics plc",
        "company_price": "1.4200",
        "company_change": 0,
        "company_percent_change": 0,
        "company_optionable": 0,
        "company_number_of_shares": 3200000,
        "price_change_sparkline": [
            [
                1.0e-6,
                1704171600
            ],
            [
                1.0e-6,
                1704258000
            ],
            [
                1.0e-6,
                1704344400
            ],
            [
                1.0e-6,
                1704430800
            ],
            [
                1.0e-6,
                1704690000
            ],
            [
                1.0e-6,
                1704776400
            ],
            [
                0.0001,
                1704862800
            ],
            [
                0.0001,
                1704949200
            ],
            [
                0.0001,
                1705035600
            ],
            [
                0.0001,
                1705381200
            ],
            [
                0.0001,
                1705467600
            ],
            [
                0.0001,
                1705554000
            ],
            [
                0.0001,
                1705640400
            ],
            [
                1.0e-6,
                1705899600
            ],
            [
                1.0e-6,
                1705986000
            ],
            [
                1.0e-6,
                1706072400
            ],
            [
                1.0e-6,
                1706158800
            ],
            [
                1.0e-6,
                1706245200
            ],
            [
                1.0e-6,
                1706504400
            ],
            [
                1.0e-6,
                1706590800
            ],
            [
                1.0e-6,
                1706677200
            ],
            [
                0.0003,
                1706763600
            ],
            [
                0.0002,
                1706850000
            ],
            [
                0.0002,
                1707109200
            ],
            [
                0.0002,
                1707195600
            ],
            [
                0.0002,
                1707282000
            ],
            [
                0.0002,
                1707368400
            ],
            [
                0.0002,
                1707454800
            ],
            [
                0.0002,
                1707714000
            ],
            [
                0.0002,
                1707800400
            ],
            [
                0.0002,
                1707886800
            ],
            [
                0.0002,
                1707973200
            ],
            [
                0.0002,
                1708059600
            ],
            [
                0.0002,
                1708405200
            ],
            [
                0.0002,
                1708491600
            ],
            [
                0.0002,
                1708578000
            ]
        ],
        "statuses": []
    },
    {
        "id": 3013,
        "drug_name": "ABICIPAR",
        "clinical_trial_id": "",
        "has_trial_insight_page": 0,
        "indication": "Age-related macular degeneration (AMD)",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2020-06-26",
        "link": "https:\/\/news.abbvie.com\/news\/press-releases\/allergan-an-abbvie-company-and-molecular-partners-receive-complete-response-letter-from-fda-on-biologics-license-application-for-abicipar-pegol.htm?view_id=822",
        "note": "CRL issued June 26, 2020.",
        "company_entity_id": 369,
        "company_ticker": "ABBV",
        "company_name": "AbbVie Inc.",
        "company_price": "178.0900",
        "company_change": 1.34,
        "company_percent_change": 0.76,
        "company_optionable": 1,
        "company_number_of_shares": 1766473359,
        "price_change_sparkline": [
            [
                158.309045440683,
                1704171600
            ],
            [
                158.942994815493,
                1704258000
            ],
            [
                159.933540713632,
                1704344400
            ],
            [
                160.607111924367,
                1704430800
            ],
            [
                159.903824336688,
                1704690000
            ],
            [
                160.775504727051,
                1704776400
            ],
            [
                163.331113144251,
                1704862800
            ],
            [
                162.231607197316,
                1704949200
            ],
            [
                162.4,
                1705035600
            ],
            [
                161.48,
                1705381200
            ],
            [
                162.04,
                1705467600
            ],
            [
                163.3,
                1705554000
            ],
            [
                164.77,
                1705640400
            ],
            [
                165.39,
                1705899600
            ],
            [
                167.5,
                1705986000
            ],
            [
                164.22,
                1706072400
            ],
            [
                165.13,
                1706158800
            ],
            [
                164.4,
                1706245200
            ],
            [
                163.91,
                1706504400
            ],
            [
                164.92,
                1706590800
            ],
            [
                164.4,
                1706677200
            ],
            [
                167.59,
                1706763600
            ],
            [
                168.67,
                1706850000
            ],
            [
                171.26,
                1707109200
            ],
            [
                173.29,
                1707195600
            ],
            [
                175.01,
                1707282000
            ],
            [
                174.79,
                1707368400
            ],
            [
                174.08,
                1707454800
            ],
            [
                173.07,
                1707714000
            ],
            [
                173.29,
                1707800400
            ],
            [
                174.42,
                1707886800
            ],
            [
                176.59,
                1707973200
            ],
            [
                177.49,
                1708059600
            ],
            [
                175.75,
                1708405200
            ],
            [
                175.14,
                1708491600
            ],
            [
                176.75,
                1708578000
            ],
            [
                178.09,
                1708664400
            ]
        ],
        "statuses": []
    },
    {
        "id": 3013,
        "drug_name": "ABICIPAR",
        "clinical_trial_id": "",
        "has_trial_insight_page": 0,
        "indication": "Age-related macular degeneration (AMD)",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2020-06-26",
        "link": "https:\/\/news.abbvie.com\/news\/press-releases\/allergan-an-abbvie-company-and-molecular-partners-receive-complete-response-letter-from-fda-on-biologics-license-application-for-abicipar-pegol.htm?view_id=822",
        "note": "CRL issued June 26, 2020.",
        "company_entity_id": 945,
        "company_ticker": "MOLN",
        "company_name": "Molecular Partners AG",
        "company_price": "4.0100",
        "company_change": -0.39,
        "company_percent_change": -8.86,
        "company_optionable": 0,
        "company_number_of_shares": 36044706,
        "price_change_sparkline": [
            [
                4.17,
                1704171600
            ],
            [
                5,
                1704258000
            ],
            [
                4.23,
                1704344400
            ],
            [
                4.249,
                1704430800
            ],
            [
                4.75,
                1704690000
            ],
            [
                4.43,
                1704776400
            ],
            [
                4.67,
                1704862800
            ],
            [
                4.77,
                1704949200
            ],
            [
                4.77,
                1705035600
            ],
            [
                4.77,
                1705381200
            ],
            [
                4.61,
                1705467600
            ],
            [
                4.69,
                1705554000
            ],
            [
                4.56,
                1705640400
            ],
            [
                4.6,
                1705899600
            ],
            [
                4.6,
                1705986000
            ],
            [
                4.75,
                1706072400
            ],
            [
                4.62,
                1706158800
            ],
            [
                4.66,
                1706245200
            ],
            [
                4.66,
                1706504400
            ],
            [
                4.65,
                1706590800
            ],
            [
                4.78,
                1706677200
            ],
            [
                4.83,
                1706763600
            ],
            [
                4.83,
                1706850000
            ],
            [
                4.625,
                1707109200
            ],
            [
                4.69,
                1707195600
            ],
            [
                4.69,
                1707282000
            ],
            [
                4.5754,
                1707368400
            ],
            [
                4.6,
                1707454800
            ],
            [
                4.505,
                1707714000
            ],
            [
                4.485,
                1707800400
            ],
            [
                4.4133,
                1707886800
            ],
            [
                4.655,
                1707973200
            ],
            [
                4.655,
                1708059600
            ],
            [
                4.45,
                1708405200
            ],
            [
                4.44,
                1708491600
            ],
            [
                4.4,
                1708578000
            ],
            [
                4.01,
                1708664400
            ]
        ],
        "statuses": []
    },
    {
        "id": 6797,
        "drug_name": "KEYTRUDA (pembrolizumab) and LENVIMA (lenvatinib)",
        "clinical_trial_id": "",
        "has_trial_insight_page": 0,
        "indication": "Hepatocellular Carcinoma",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2020-07-08",
        "link": "https:\/\/investors.merck.com\/news\/press-release-details\/2020\/Merck-and-Eisai-Receive-Complete-Response-Letter-for-KEYTRUDA-pembrolizumab-plus-LENVIMA-lenvatinib-Combination-as-First-Line-Treatment-for-Unresectable-Hepatocellular-Carcinoma\/default.aspx",
        "note": "CRL issued July 8, 2020.",
        "company_entity_id": 383,
        "company_ticker": "MRK",
        "company_name": "Merck & Company Inc.",
        "company_price": "129.4500",
        "company_change": 0.19,
        "company_percent_change": 0.15,
        "company_optionable": 1,
        "company_number_of_shares": 2534023084,
        "price_change_sparkline": [
            [
                113.24,
                1704171600
            ],
            [
                114.77,
                1704258000
            ],
            [
                117.01,
                1704344400
            ],
            [
                117.22,
                1704430800
            ],
            [
                117.38,
                1704690000
            ],
            [
                118.43,
                1704776400
            ],
            [
                118.86,
                1704862800
            ],
            [
                118.43,
                1704949200
            ],
            [
                118.63,
                1705035600
            ],
            [
                118.49,
                1705381200
            ],
            [
                118.13,
                1705467600
            ],
            [
                118.54,
                1705554000
            ],
            [
                118.89,
                1705640400
            ],
            [
                119.43,
                1705899600
            ],
            [
                119.84,
                1705986000
            ],
            [
                118.88,
                1706072400
            ],
            [
                120.13,
                1706158800
            ],
            [
                120.82,
                1706245200
            ],
            [
                121.28,
                1706504400
            ],
            [
                121.66,
                1706590800
            ],
            [
                120.78,
                1706677200
            ],
            [
                126.38,
                1706763600
            ],
            [
                126.41,
                1706850000
            ],
            [
                126.18,
                1707109200
            ],
            [
                126.88,
                1707195600
            ],
            [
                127.47,
                1707282000
            ],
            [
                126.61,
                1707368400
            ],
            [
                125.45,
                1707454800
            ],
            [
                125.34,
                1707714000
            ],
            [
                125.43,
                1707800400
            ],
            [
                125.82,
                1707886800
            ],
            [
                126.54,
                1707973200
            ],
            [
                127.79,
                1708059600
            ],
            [
                127.37,
                1708405200
            ],
            [
                128.12,
                1708491600
            ],
            [
                129.26,
                1708578000
            ],
            [
                129.45,
                1708664400
            ]
        ],
        "statuses": []
    },
    {
        "id": 3485,
        "drug_name": "Viaskin Peanut - (PEOPLE)",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Peanut allergy - ages 4 to 11 years",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2020-08-04",
        "link": "https:\/\/ml-eu.globenewswire.com\/Resource\/Download\/49833231-75bf-40b7-b9b3-d57b9c1578f8",
        "note": "CRL issued August 4, 2020",
        "company_entity_id": 114,
        "company_ticker": "DBVT",
        "company_name": "DBV Technologies S.A.",
        "company_price": "0.8390",
        "company_change": 0.02,
        "company_percent_change": 2.94,
        "company_optionable": 1,
        "company_number_of_shares": 192577106,
        "price_change_sparkline": [
            [
                0.9473,
                1704171600
            ],
            [
                0.88,
                1704258000
            ],
            [
                0.9065,
                1704344400
            ],
            [
                0.8662,
                1704430800
            ],
            [
                0.9001,
                1704690000
            ],
            [
                0.93,
                1704776400
            ],
            [
                0.91,
                1704862800
            ],
            [
                0.8718,
                1704949200
            ],
            [
                0.9,
                1705035600
            ],
            [
                0.8714,
                1705381200
            ],
            [
                0.86,
                1705467600
            ],
            [
                0.831,
                1705554000
            ],
            [
                0.83,
                1705640400
            ],
            [
                0.87,
                1705899600
            ],
            [
                0.88,
                1705986000
            ],
            [
                0.87,
                1706072400
            ],
            [
                0.9067,
                1706158800
            ],
            [
                0.895,
                1706245200
            ],
            [
                0.9126,
                1706504400
            ],
            [
                0.87,
                1706590800
            ],
            [
                0.917,
                1706677200
            ],
            [
                0.89,
                1706763600
            ],
            [
                0.9,
                1706850000
            ],
            [
                0.8911,
                1707109200
            ],
            [
                0.89255,
                1707195600
            ],
            [
                0.888,
                1707282000
            ],
            [
                0.8689,
                1707368400
            ],
            [
                0.85095,
                1707454800
            ],
            [
                0.86,
                1707714000
            ],
            [
                0.849,
                1707800400
            ],
            [
                0.85,
                1707886800
            ],
            [
                0.8554,
                1707973200
            ],
            [
                0.85,
                1708059600
            ],
            [
                0.7856,
                1708405200
            ],
            [
                0.8101,
                1708491600
            ],
            [
                0.815,
                1708578000
            ],
            [
                0.839,
                1708664400
            ]
        ],
        "statuses": []
    },
    {
        "id": 3106,
        "drug_name": "RYANODEX (dantrolene sodium)",
        "clinical_trial_id": "",
        "has_trial_insight_page": 0,
        "indication": "Exertional heat stroke (EHS)",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2020-08-10",
        "link": "https:\/\/www.businesswire.com\/news\/home\/20200810005181\/en\/",
        "note": "CRL announced August 10, 2020.",
        "company_entity_id": 128,
        "company_ticker": "EGRX",
        "company_name": "Eagle Pharmaceuticals Inc.",
        "company_price": "6.2500",
        "company_change": 0.38,
        "company_percent_change": 6.47,
        "company_optionable": 1,
        "company_number_of_shares": 12986971,
        "price_change_sparkline": [
            [
                5.66,
                1704171600
            ],
            [
                5.23,
                1704258000
            ],
            [
                5.23,
                1704344400
            ],
            [
                5.13,
                1704430800
            ],
            [
                4.91,
                1704690000
            ],
            [
                4.84,
                1704776400
            ],
            [
                4.78,
                1704862800
            ],
            [
                4.5,
                1704949200
            ],
            [
                4.53,
                1705035600
            ],
            [
                4.26,
                1705381200
            ],
            [
                4.36,
                1705467600
            ],
            [
                4.53,
                1705554000
            ],
            [
                4.48,
                1705640400
            ],
            [
                4.42,
                1705899600
            ],
            [
                4.73,
                1705986000
            ],
            [
                4.94,
                1706072400
            ],
            [
                5.3,
                1706158800
            ],
            [
                5.41,
                1706245200
            ],
            [
                5.51,
                1706504400
            ],
            [
                5.48,
                1706590800
            ],
            [
                5.86,
                1706677200
            ],
            [
                6.08,
                1706763600
            ],
            [
                5.85,
                1706850000
            ],
            [
                5.6,
                1707109200
            ],
            [
                4.9,
                1707195600
            ],
            [
                5.165,
                1707282000
            ],
            [
                5.32,
                1707368400
            ],
            [
                5.32,
                1707454800
            ],
            [
                5.6,
                1707714000
            ],
            [
                5.21,
                1707800400
            ],
            [
                5.25,
                1707886800
            ],
            [
                5.85,
                1707973200
            ],
            [
                5.97,
                1708059600
            ],
            [
                5.99,
                1708405200
            ],
            [
                6.23,
                1708491600
            ],
            [
                5.87,
                1708578000
            ],
            [
                6.25,
                1708664400
            ]
        ],
        "statuses": []
    },
    {
        "id": 4977,
        "drug_name": "TRC 101",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Chronic kidney disease",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2020-08-24",
        "link": "https:\/\/www.benzinga.com\/pressreleases\/20\/08\/b17207152\/tricida-receives-complete-response-letter-from-the-fda-for-its-new-drug-application-for-veverimer-",
        "note": "CRL announced August 24, 2020.",
        "company_entity_id": 567,
        "company_ticker": "TCDA",
        "company_name": "Tricida Inc.",
        "company_price": "0.1080",
        "company_change": 0,
        "company_percent_change": 0,
        "company_optionable": 0,
        "company_number_of_shares": 58028254,
        "statuses": []
    },
    {
        "id": 5256,
        "drug_name": "Cysteine Inj (DS-300)",
        "clinical_trial_id": "",
        "has_trial_insight_page": 0,
        "indication": "Nutritional deficiencies",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2020-11-12",
        "link": "https:\/\/ir.etonpharma.com\/news-releases\/news-release-details\/eton-pharmaceuticals-announces-third-quarter-2020-financial",
        "note": "CRL received October 2020 (announced November 12, 2020).",
        "company_entity_id": 611,
        "company_ticker": "ETON",
        "company_name": "Eton Pharmaceuticals Inc.",
        "company_price": "4.4700",
        "company_change": 0,
        "company_percent_change": 0,
        "company_optionable": 1,
        "company_number_of_shares": 25658396,
        "price_change_sparkline": [
            [
                4.59,
                1704171600
            ],
            [
                4.63,
                1704258000
            ],
            [
                4.64,
                1704344400
            ],
            [
                4.34,
                1704430800
            ],
            [
                5.03,
                1704690000
            ],
            [
                4.93,
                1704776400
            ],
            [
                4.86,
                1704862800
            ],
            [
                4.74,
                1704949200
            ],
            [
                4.37,
                1705035600
            ],
            [
                4.09,
                1705381200
            ],
            [
                4.14,
                1705467600
            ],
            [
                4.08,
                1705554000
            ],
            [
                4.14,
                1705640400
            ],
            [
                4.39,
                1705899600
            ],
            [
                4.47,
                1705986000
            ],
            [
                4.45,
                1706072400
            ],
            [
                4.44,
                1706158800
            ],
            [
                4.56,
                1706245200
            ],
            [
                4.71,
                1706504400
            ],
            [
                4.74,
                1706590800
            ],
            [
                4.67,
                1706677200
            ],
            [
                4.6,
                1706763600
            ],
            [
                4.49,
                1706850000
            ],
            [
                4.58,
                1707109200
            ],
            [
                4.72,
                1707195600
            ],
            [
                4.58,
                1707282000
            ],
            [
                4.41,
                1707368400
            ],
            [
                4.41,
                1707454800
            ],
            [
                4.41,
                1707714000
            ],
            [
                4.42,
                1707800400
            ],
            [
                4.39,
                1707886800
            ],
            [
                4.59,
                1707973200
            ],
            [
                4.4,
                1708059600
            ],
            [
                4.36,
                1708405200
            ],
            [
                4.45,
                1708491600
            ],
            [
                4.47,
                1708578000
            ],
            [
                4.47,
                1708664400
            ]
        ],
        "statuses": []
    },
    {
        "id": 1888,
        "drug_name": "Sutimlimab (BIVV009) - Cardinal",
        "clinical_trial_id": "NCT03347396",
        "has_trial_insight_page": 0,
        "indication": "Cold agglutinin disease",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2020-11-13",
        "link": "https:\/\/ml-eu.globenewswire.com\/Resource\/Download\/f7de0b1a-7b9c-4cf9-812b-6652f8e671ea",
        "note": "CRL issued November 13, 2020.",
        "company_entity_id": 389,
        "company_ticker": "SNY",
        "company_name": "Sanofi",
        "company_price": "48.7700",
        "company_change": 0.97,
        "company_percent_change": 2.03,
        "company_optionable": 1,
        "company_number_of_shares": 2521671464,
        "price_change_sparkline": [
            [
                50,
                1704171600
            ],
            [
                50.61,
                1704258000
            ],
            [
                51.01,
                1704344400
            ],
            [
                51.21,
                1704430800
            ],
            [
                51.99,
                1704690000
            ],
            [
                51.76,
                1704776400
            ],
            [
                52.41,
                1704862800
            ],
            [
                52.48,
                1704949200
            ],
            [
                52.21,
                1705035600
            ],
            [
                51.56,
                1705381200
            ],
            [
                51.64,
                1705467600
            ],
            [
                51.88,
                1705554000
            ],
            [
                51.03,
                1705640400
            ],
            [
                50.83,
                1705899600
            ],
            [
                49.89,
                1705986000
            ],
            [
                49.89,
                1706072400
            ],
            [
                49.88,
                1706158800
            ],
            [
                50.14,
                1706245200
            ],
            [
                50.28,
                1706504400
            ],
            [
                50.25,
                1706590800
            ],
            [
                49.9,
                1706677200
            ],
            [
                48.41,
                1706763600
            ],
            [
                47.23,
                1706850000
            ],
            [
                46.95,
                1707109200
            ],
            [
                47.06,
                1707195600
            ],
            [
                46.92,
                1707282000
            ],
            [
                46.56,
                1707368400
            ],
            [
                46.5,
                1707454800
            ],
            [
                46.34,
                1707714000
            ],
            [
                45.75,
                1707800400
            ],
            [
                45.8,
                1707886800
            ],
            [
                46.39,
                1707973200
            ],
            [
                46.18,
                1708059600
            ],
            [
                46.85,
                1708405200
            ],
            [
                47.92,
                1708491600
            ],
            [
                47.8,
                1708578000
            ],
            [
                48.77,
                1708664400
            ]
        ],
        "statuses": []
    },
    {
        "id": 1921,
        "drug_name": "FUROSCIX (furosemide)",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Heart failure",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2020-12-07",
        "link": "https:\/\/www.benzinga.com\/pressreleases\/20\/12\/g18670683\/scpharmaceuticals-inc-receives-complete-response-letter-from-fda-for-furoscix",
        "note": "CRL announced December 7, 2020.",
        "company_entity_id": 478,
        "company_ticker": "SCPH",
        "company_name": "scPharmaceuticals Inc.",
        "company_price": "5.6600",
        "company_change": 0.02,
        "company_percent_change": 0.35,
        "company_optionable": 1,
        "company_number_of_shares": 35860497,
        "price_change_sparkline": [
            [
                6.39,
                1704171600
            ],
            [
                6.35,
                1704258000
            ],
            [
                6.36,
                1704344400
            ],
            [
                6.35,
                1704430800
            ],
            [
                6.39,
                1704690000
            ],
            [
                6.28,
                1704776400
            ],
            [
                6.35,
                1704862800
            ],
            [
                6.1,
                1704949200
            ],
            [
                5.97,
                1705035600
            ],
            [
                5.78,
                1705381200
            ],
            [
                5.77,
                1705467600
            ],
            [
                5.76,
                1705554000
            ],
            [
                5.34,
                1705640400
            ],
            [
                5.52,
                1705899600
            ],
            [
                5.47,
                1705986000
            ],
            [
                5.27,
                1706072400
            ],
            [
                5.45,
                1706158800
            ],
            [
                5.32,
                1706245200
            ],
            [
                5.39,
                1706504400
            ],
            [
                5.09,
                1706590800
            ],
            [
                4.9,
                1706677200
            ],
            [
                5.09,
                1706763600
            ],
            [
                4.91,
                1706850000
            ],
            [
                5.19,
                1707109200
            ],
            [
                5.32,
                1707195600
            ],
            [
                5.2,
                1707282000
            ],
            [
                5.11,
                1707368400
            ],
            [
                5.38,
                1707454800
            ],
            [
                5.73,
                1707714000
            ],
            [
                5.35,
                1707800400
            ],
            [
                5.64,
                1707886800
            ],
            [
                5.68,
                1707973200
            ],
            [
                5.74,
                1708059600
            ],
            [
                5.7,
                1708405200
            ],
            [
                5.58,
                1708491600
            ],
            [
                5.64,
                1708578000
            ],
            [
                5.66,
                1708664400
            ]
        ],
        "statuses": []
    },
    {
        "id": 5511,
        "drug_name": "KEYTRUDA (pembrolizumab)",
        "clinical_trial_id": "",
        "has_trial_insight_page": 0,
        "indication": "Small cell lung cancer (SCLC)",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2021-03-01",
        "link": "https:\/\/www.businesswire.com\/news\/home\/20210301005851\/en\/",
        "note": "FDA Approval announced June 18, 2019. Approval withdrawn March 1, 2021 due to not meeting post-marketing requirements following accelerated approval.",
        "company_entity_id": 383,
        "company_ticker": "MRK",
        "company_name": "Merck & Company Inc.",
        "company_price": "129.4500",
        "company_change": 0.19,
        "company_percent_change": 0.15,
        "company_optionable": 1,
        "company_number_of_shares": 2534023084,
        "price_change_sparkline": [
            [
                113.24,
                1704171600
            ],
            [
                114.77,
                1704258000
            ],
            [
                117.01,
                1704344400
            ],
            [
                117.22,
                1704430800
            ],
            [
                117.38,
                1704690000
            ],
            [
                118.43,
                1704776400
            ],
            [
                118.86,
                1704862800
            ],
            [
                118.43,
                1704949200
            ],
            [
                118.63,
                1705035600
            ],
            [
                118.49,
                1705381200
            ],
            [
                118.13,
                1705467600
            ],
            [
                118.54,
                1705554000
            ],
            [
                118.89,
                1705640400
            ],
            [
                119.43,
                1705899600
            ],
            [
                119.84,
                1705986000
            ],
            [
                118.88,
                1706072400
            ],
            [
                120.13,
                1706158800
            ],
            [
                120.82,
                1706245200
            ],
            [
                121.28,
                1706504400
            ],
            [
                121.66,
                1706590800
            ],
            [
                120.78,
                1706677200
            ],
            [
                126.38,
                1706763600
            ],
            [
                126.41,
                1706850000
            ],
            [
                126.18,
                1707109200
            ],
            [
                126.88,
                1707195600
            ],
            [
                127.47,
                1707282000
            ],
            [
                126.61,
                1707368400
            ],
            [
                125.45,
                1707454800
            ],
            [
                125.34,
                1707714000
            ],
            [
                125.43,
                1707800400
            ],
            [
                125.82,
                1707886800
            ],
            [
                126.54,
                1707973200
            ],
            [
                127.79,
                1708059600
            ],
            [
                127.37,
                1708405200
            ],
            [
                128.12,
                1708491600
            ],
            [
                129.26,
                1708578000
            ],
            [
                129.45,
                1708664400
            ]
        ],
        "statuses": []
    },
    {
        "id": 7061,
        "drug_name": "Arimoclomol",
        "clinical_trial_id": "NCT02612129",
        "has_trial_insight_page": 0,
        "indication": "Niemann-Pick disease Type C (NPC)",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2021-06-18",
        "link": "https:\/\/www.globenewswire.com\/news-release\/2021\/06\/18\/2249393\/0\/en\/Orphazyme-provides-regulatory-update-from-FDA-on-arimoclomol-for-Niemann-Pick-disease-type-C.html",
        "note": "CRL issued June 18, 2021.",
        "company_entity_id": 2030,
        "company_ticker": "ZVRA",
        "company_name": "Zevra Therapeutics Inc.",
        "company_price": "6.6300",
        "company_change": -0.17000000000000004,
        "company_percent_change": -2.5,
        "company_optionable": 1,
        "company_number_of_shares": 36218164,
        "price_change_sparkline": [
            [
                6.83,
                1704171600
            ],
            [
                6.42,
                1704258000
            ],
            [
                6.15,
                1704344400
            ],
            [
                5.94,
                1704430800
            ],
            [
                6.35,
                1704690000
            ],
            [
                6.185,
                1704776400
            ],
            [
                6.02,
                1704862800
            ],
            [
                6.03,
                1704949200
            ],
            [
                5.92,
                1705035600
            ],
            [
                5.82,
                1705381200
            ],
            [
                5.76,
                1705467600
            ],
            [
                5.71,
                1705554000
            ],
            [
                5.72,
                1705640400
            ],
            [
                5.97,
                1705899600
            ],
            [
                5.94,
                1705986000
            ],
            [
                5.74,
                1706072400
            ],
            [
                5.87,
                1706158800
            ],
            [
                5.975,
                1706245200
            ],
            [
                6.17,
                1706504400
            ],
            [
                5.93,
                1706590800
            ],
            [
                5.79,
                1706677200
            ],
            [
                5.96,
                1706763600
            ],
            [
                5.78,
                1706850000
            ],
            [
                5.77,
                1707109200
            ],
            [
                5.905,
                1707195600
            ],
            [
                5.81,
                1707282000
            ],
            [
                5.95,
                1707368400
            ],
            [
                6.15,
                1707454800
            ],
            [
                6.11,
                1707714000
            ],
            [
                5.76,
                1707800400
            ],
            [
                6.14,
                1707886800
            ],
            [
                6.68,
                1707973200
            ],
            [
                6.86,
                1708059600
            ],
            [
                6.89,
                1708405200
            ],
            [
                6.78,
                1708491600
            ],
            [
                6.8,
                1708578000
            ],
            [
                6.63,
                1708664400
            ]
        ],
        "statuses": []
    },
    {
        "id": 3638,
        "drug_name": "NexoBrid",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Severe burns",
        "label": "CRL",
        "value": "crl",
        "simplified_stage": "phase6",
        "stageid": 16,
        "stage_name": "CRL",
        "date": "2021-06-29",
        "link": "https:\/\/www.benzinga.com\/pressreleases\/21\/06\/g21764139\/mediwound-receives-complete-response-letter-from-u-s-fda-for-nexobrid-biologics-license-applicatio",
        "note": "CRL announced June 29, 2021.",
        "company_entity_id": 302,
        "company_ticker": "VCEL",
        "company_name": "Vericel Corporation",
        "company_price": "47.3200",
        "company_change": -0.99,
        "company_percent_change": -2.05,
        "company_optionable": 1,
        "company_number_of_shares": 47724543,
        "price_change_sparkline": [
            [
                34.88,
                1704171600
            ],
            [
                33.87,
                1704258000
            ],
            [
                34,
                1704344400
            ],
            [
                32.52,
                1704430800
            ],
            [
                34.79,
                1704690000
            ],
            [
                37.31,
                1704776400
            ],
            [
                37.33,
                1704862800
            ],
            [
                37.39,
                1704949200
            ],
            [
                38.24,
                1705035600
            ],
            [
                39.2,
                1705381200
            ],
            [
                37.83,
                1705467600
            ],
            [
                39.16,
                1705554000
            ],
            [
                39.67,
                1705640400
            ],
            [
                42.03,
                1705899600
            ],
            [
                42.25,
                1705986000
            ],
            [
                40.82,
                1706072400
            ],
            [
                42.6,
                1706158800
            ],
            [
                42.6,
                1706245200
            ],
            [
                44.56,
                1706504400
            ],
            [
                44.26,
                1706590800
            ],
            [
                42.98,
                1706677200
            ],
            [
                43.65,
                1706763600
            ],
            [
                42.89,
                1706850000
            ],
            [
                43.22,
                1707109200
            ],
            [
                44.16,
                1707195600
            ],
            [
                44.23,
                1707282000
            ],
            [
                45.85,
                1707368400
            ],
            [
                46.78,
                1707454800
            ],
            [
                47.42,
                1707714000
            ],
            [
                45.95,
                1707800400
            ],
            [
                47.56,
                1707886800
            ],
            [
                49.37,
                1707973200
            ],
            [
                49.2,
                1708059600
            ],
            [
                49.5,
                1708405200
            ],
            [
                48.13,
                1708491600
            ],
            [
                48.31,
                1708578000
            ],
            [
                47.32,
                1708664400
            ]
        ],
        "statuses": []
    }
]

